Peripheral T cell expansion predicts tumour infiltration and clinical response

By Thomas D Wu, Shravan Madireddi, Patricia E. de Almeida, R. Banchereau, Y. Chen, Avantika Chitre, E. Chiang, Hina Iftikhar, W. O'Gorman, A. Au-Yeung and 19 more. Nature, 2020

630 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/0f494b62280099e95ae1dedeeceb55394a24d4cf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Zemin Zhang

In Oncology

1. Zemin Zhang

Citations in the corpus

• Tumor-infiltrating lymphocytes in the immunotherapy era (2020, background): “Complementary research has demonstrated an increased prevalence of TRM cells in treatmentnaive tumors versus healthy adjacent tissue, as well as demonstrating that ICB responders are characterized by CD8 TCM cell accumulation.(193) During ICB, these TCM cells develop an effectorlike phenotype with a”
• Pan-cancer single-cell landscape of tumor-infiltrating T cells (2021, background): “However, direct comparative studies have been restricted to only three or four isolated cancer types (11, 12).”